We have previously observed that the urinary excretion of citrate is reduced to low levels in rats treated with the carbonic anhydrase inhibitor, acetazoleamide (Diamox®g) (1). This first experiment was prompted by the fact that the elevated serum chloride and decreased serum bicar-. bonate concentrations, and the fixation of the urine pH at approximately 7 or above following administration of an agent which inhibits carbonic anhydrase activity resembles the findings in patients with congenital renal tubular acidosis. In a study of an infant with this syndrome we found that the urinary excretion of citrate was too low to be measured (1). The absence of citrate in the urine of this patient persisted even after the hyperchloremia and acidosis were corrected by administration of 40 mM of sodium lactate daily and the urine pH was raised to about 8.0. This is in contrast to the findings in normal subjects in whom the renal excretion of citrate increases when the urine is made alkaline by administration of sodium or potassium bicarbonate or the sodium and potassium salts of organic acids (2). It has also 
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METHODS
The importance of urine citrate as a complexing agent could be tested by means of the effect of acetazoleamide upon renal excretion of citrate. These studies were devised to determine whether the increased citraturia due to administration of alkalinizing salts or of vitamin D could be inhibited by acetazoleamide and whether reduction of urinary excretion of citrate following acetazoleamide might be associated with precipitation of calcium salts in the renal tubules and formation of renal calculi. Three to four-week-old male albino rats of the SpragueDawley strain were placed on purified experimental diets for three weeks. At this time, when they had reached a weight of about 100 gm., they were divided into two groups, one a control and the other acetazoleamidetreated. Two diets were used which differed in their content of Ca and P and in their acid-base ratio as summarized in Table I . When acetazoleamide was given it was incorporated in the diet in the ratio of 250 mg. of drug per 100 gm. diet. The average daily dosage calculated from food intake was approximately 15 to 20 mg. per 100 gm. of body weight. The basic diets did not supply vitamin D which was added as mentioned in the description of the separate experiments. The animals were kept in metabolism cages permitting collection of urine without contamination by feces or spilled food and the urine was collected under toluene. Citrate in serum and urine was determined by the method of Natelson, Pincus, and Lugovoy (6) . Calcium in urine was determined by the Clark-Collip modification of the Kramer-Tisdall method (7) , and in serum by this method or by a micro method developed in this laboratory (8) . Phosphorus was determined by the Fiske and Subbarow technique (9) . Urine pH was measured by indicators.
In Figure 1 is shown the effect of acetazoleamide upon the urinary excretions of calcium and citrate of a rat fed diet A which is an alkaline ash, high calcium, low phosphorus ration. Although no vitamin D was given, the urinary excretions of citrate in the control period are considerable because of the marked cation excess (urine pH approximately 8.0). The sharp drop in citrate excretion following acetazoleamide addition is evident. The urine citrate output returns to control levels when the drug is discontinued and decreases again when it is resumed. The urinary excretion of phosphorus on this diet is negligible and is not influenced by the drug. The urinary excretion of calcium in the control period is high and there may be some inconstant decrease following acetazoleamide. The precipitous fall in urine citrate after acetazoleamide feeding is a consistent finding as is shown in Table II , which summarizes the results in six rats on diet A, four acetazoleamide fed and two control animals. the high calcium, low phosphorus diet but the urinary excretion of calcium is reduced and urinary excretion of phosphate remains low. The inhibitory effect of acetazoleamide upon citrate excretion is still apparent despite the sodium citrate supplement although the urinary citrate is not reduced to the extremely low levels found in rats fed diet A without added sodium citrate. No evidence of refractoriness to the acetazoleamide effect on urine citrate excretion was found in rats treated continuously for three weeks. In a few experiments, doses of Diamox®9 of only 4 to 5 mg. per 100 gin. body weight per day were also effective in reducing urine citrate output to the same minimal values shown in Table II .
In Figures 2 and 3 are shown the effects of acetazoleamide upon vitamin D induced citraturia. In this experiment the animals were fed diet C in which the Ca to P ratio and the content of these elements per calorie of diet is approximately the same as in cow's milk. This is an acid ash diet and in the vitamin D deficient state the urinary citrate excretion is less than 0.5 mg. per day. The effect of the administration of a single dose of 5,000 units of vitamin D upon citraturia in a control rat is shown in Figure 2 . The rapid increase of urinary citrate excretion to values of about 10 mg. per day following vitamin D is roughly paralleled by an increase in urinary excretion of both calcium and phosphorus. The increased urinary output of calcium and phosphorus presumably reflects increased intestinal absorption of these minerals due to vitamin D effect. Figure 3 shows a similar study in an acetazoleamide treated rat. The drug was added to the diet two days prior to the administration of vitamin D The expected increase in citraturia due to vitamin D is almost completely prevented although the increased urinary output of calcium and phosphorus is approximately the same as in the control vitamin D treated rat. Similar results were obtained in three other rats on this regime. Urinary pH values ranged about 6.0 in the rats fed this diet without acetazoleamide and were about 0.5 pH unit higher in the acetazoleamide-fed rats. If urine citrate plays an important role in maintaining urinary calcium in solution as has been suggested by Kissin and Locks (10), Shorr, Almy, Sloan, Taussky, and Toscani (3), and Scott, Huggins, and Selman (11) the inhibition of citraturia by acetazoleamide without proportionate decrease of urine calcium excretion should conduce to the precipitation of calcium salts in the urinary tract. Six rats of the group fed diet C were given a single dose of 5,000 units of vitamin D. Four were fed acetazoleamide for a period of three weeks and two were maintained on the control diet. At the end of a three-week period the rats were sacrificed and blood samples and the kidneys were taken for analysis. The animals were not fasted and the treated rats received the Diamox@ containing diet up to the time they were sacrificed.
The concentrations of calcium, phosphorus, and citrate in the serum of these animals are given in Table IV . The serum citrate values are essentially the same in control and treated rats despite marked differences in urinary excretion of citrate. Three additional control rats on this dietary regime had serum citrate concentrations of 3.0, 3.3 and 3.7 mg. per 100 cc., respectively. The serum calcium and phosphorus levels of both control and treated rats are all in the normal range for rats of this age although the serum phosphorus values are slightly higher in the treated animals. Half of each kidney was taken for chemical analysis and half for histological examination. The kidneys were ashed and calcium determined in the ash solution. The calcium contents of the kidneys are shown in Table V . The kidneys of the two control animals contained too little calcium to be determined accurately and also showed no evidences of calcium precipitate on histological examination. The kidneys of the four acetazoleamide-fed rats contained between 27 and 355 mg.
of calcium per 100 gin. fresh kidney. The location of the calcium deposits in the kidneys was determined by histological examination. The sections in Figure 4 stained by the von Kossa method show precipitated calcium in the kidney tubules chiefly at the cortico-medullary junction. The precipitated material is intratubular although the tubules are in many places disrupted by the precipitate. There is no histological evidence of Table V . The kidneys of the rats not receiving acetazoleamide showed only small amounts of calcium although the urine of these animals contained high concentrations of calcium. The kidneys of the control rats were normal both on gross and microscopic examination. Analyses of the kidneys of the acetazoleamide-fed rats showed considerable quantities of calcium. The pathological findings in these kidneys, however, differed from those seen in the kidneys of the rats fed diet C. On gross examination calculi of various sizes were found in the renal pelvis adherent to the renal papilla in almost all of the kidneys of the acetazoleamide-treated group. In one animal a calculus, weighing about 5 mg. had broken off and lodged in the bladder. This Whatever the mechanism which may be involved in the reduction of urinary citrate by acetazoleamide the sequence of events observed, namely, increase of urinary pH and decrease of urinary citrate without proportionate decrease in calcium or phosphate excretion evidently predisposes to precipitation of calcium in the renal tubules or in the upper urinary tract. These findings support the idea that urinary citrate does increase the solubility of calcium in urine by virtue of its property of forming an undissociated calcium complex and that this mechanism is of importance in the prevention of calcium precipitation in the kidney. The molar ratio of calcium to citrate in the urine of the control rats not receiving acetazoleamide ranged from 3: 1 to 3: 2. No studies were made to determine whether there might be other polycarboxylic acids excreted in the urine which could sequester calcium.
The site of precipitation of calcium in the urinary tract in these experiments is apparently determined by the concentration of phosphate in the urine. In both experiments the diets were such as to produce calcuria although the urine calcium excretion was greater in the rats fed diet A. In the animals fed diet C supplemented with vitamin D the serum phosphorus concentrations are high and the phosphate load exceeds the renal tubular capacity to reabsorb phosphate so that the urine excreted contains phosphate. Under these conditions phosphate may be assumed to be present in the fluid leaving the proximal convoluted tubules. In the acetazoleamide-treated rats of this series calcium phosphate is precipitated in the renal tubules probably as the result of disappearance of citrate and also increase of pH of the tubular contents. The localization of the precipitate is of theoretical interest since the acetazoleamide effect upon citrate concentration or urine pH must presumably be exerted proximal to or in the portion of the tubule where precipitation of calcium phosphate occurs. The histological pattern of involvement of the tubules at the cortico-medullary junction, and the configuration of the tubular casts in the cleared specimen suggests that the precipitate is in the terminal or straight segment of the proximal convoluted tubule. Isolation of single nephrons by micro-dissection would be necessary to demonstrate conclusively the segment of the tubule in which precipitation occurs.
The feeding of a high calcium, low phosphate diet reduces the serum phosphorus level and therefore the phosphate filtered so that practically all of the phosphate filtered is reabsorbed in the proximal tubule. In the absence of phosphate in the tubular contents no calcium precipitation occurs in the upper nephron despite lack of citrate. Precipitation is found only at the tips of the papillary ducts with formation of calculi in the renal pelvis. Decrease in CO2 tension with increase of pH or the physical factors of eddy currents and stasis may be involved in the precipitation of calcium from a supersaturated solution at this site.
The modifying effect of dietary factors upon precipitation of calcium in the kidney may explain the fact that such calcification has not been found by other workers who have been investigating acetazoleamide effect upon kidney function. Maren, Mayer, and Wadsworth (15) did note renal calcification in a few rats receiving very large doses of Diamoxg, 900 mg. per Kg. No reports of renal calculus formation in patients receiving Diamoxg have been published. The dosages given to patients in terms of body weight are much smaller than those used in the rat but the amounts used in these experiments are considerably greater than those needed to inhibit urine citrate excretion. Studies of the effect of Diamox® upon the urinary excretion of citrate, calcium, and phosphate in human subjects are needed before any conclusion can be drawn concerning the possibility of the development of renal calcinosis in patients receiving this drug. The renal calcification found in patients with renal tubular acidosis (16) might indeed be associated with an abnormality of urine citrate excretion in view of the extremely low urine citrate levels found in an infant with this syndrome.
SUMMARY
Administration of acetazoleamide to rats results in reduction of urinary citrate excretion to extremely low levels. The usual effect of cation excess or of vitamin D in increasing citraturia is inhibited by acetazoleamide.
The feeding of acetazoleamide to rats also causes the precipitation of calcium salts in the kidney or lower urinary tract under certain dietary conditions. On a diet which resembles cow's milk in its content of calcium and phosphorus, calcium phosphate is precipitated in the renal tubules at the cortico-medullary junction. If the diet is low in phosphate and high in calcium, calcified plaques are formed at the tips of the papillary ducts with formation of calculi in the pelvis. These findings indicate that the concentration of citrate in urine is of physiological importance in the stabilization of urinary calcium and that calcuria in the absence of urinary citrate results in precipitation of the calcium. The nature of the precipitate and its location in the renal tubule is apparently dependent upon the concentration of phosphate in the urine. The site of intratubular precipitation of calcium in the acetazoleamide-treated rats fed the high calcium and phosphorus diet suggests that the acetazoleamide effect upon citrate occurs in the proximal portion of the tubule.
